FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine how safe, tolerable and effective the new
standardised dosage regimen of FERINJECT® infusions is, compared with a well established
intravenous iron treatment.